Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively... Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States. Mehr anzeigen
Seven participants across two cohorts dosed in the Heart-2 Phase 1b clinical trial of VERVE-102 targeting PCSK9; Initial data planned for the first half of 2025 First participant dosed in the...
BOSTON , Nov. 01, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on October...
Verve Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VERV PR Newswire LOS ANGELES, Oct. 28, 2024 LOS ANGELES, Oct. 28, 2024 /PRNewswire/...
Verve Therapeutics, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before October 28, 2024 to Discuss Your Rights - VERV PR Newswire NEW YORK, Oct. 28, 2024 NEW YORK, Oct...
Verve Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VERV PR Newswire LOS ANGELES, Oct. 23, 2024 LOS ANGELES, Oct. 23, 2024 /PRNewswire/...
Verve Therapeutics, Inc. Class Action: The Gross Law Firm Reminds Verve Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - VERV PR...
Class Action Filed Against Verve Therapeutics, Inc. (VERV) - October 28, 2024 Deadline to Join - Contact The Gross Law Firm PR Newswire NEW YORK, Oct. 14, 2024 NEW YORK, Oct. 14, 2024...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.47 | 9.71074380165 | 4.84 | 5.48 | 4.44 | 1432679 | 4.93838167 | CS |
| 4 | -0.61 | -10.3040540541 | 5.92 | 6.77 | 4.44 | 1661982 | 5.54843745 | CS |
| 12 | -0.63 | -10.6060606061 | 5.94 | 6.77 | 4.37 | 1343200 | 5.40845581 | CS |
| 26 | -0.06 | -1.11731843575 | 5.37 | 7.96 | 4.305 | 1382867 | 5.5513069 | CS |
| 52 | -7.11 | -57.2463768116 | 12.42 | 19.34 | 4.305 | 1344380 | 8.13956766 | CS |
| 156 | -28.62 | -84.350132626 | 33.93 | 43 | 4.305 | 1035563 | 15.79763258 | CS |
| 260 | -24.69 | -82.3 | 30 | 78 | 4.305 | 954560 | 17.8443324 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
